Stryker sees FY25 adjusted EPS $13.40-$13.60, consensus $13.36

The company said, “Considering our year-to-date results, strong demand for our products and our operational momentum, we are raising our full year 2025 guidance and now expect organic net sales growth of 9.5% to 10.0% and adjusted net earnings per diluted share to be in the range of $13.40 to $13.60. Our updated sales guidance includes a modestly favorable pricing impact. In addition, foreign exchange is expected to have a slightly positive impact on both sales and adjusted net earnings per diluted share should rates hold near current levels. We now estimate a net impact from tariffs in 2025 of approximately $175 million. This estimate reflects the latest updates since the date of our last earnings press release, including a reduction in bilateral United States and China tariffs as well as the recent announcement of the proposed tariff framework between the United States and the European Union.”